FDA is encouraging pharmaceutical companies to develop abuse deterrent pain medicines to combat opioid addiction while ensuring chronic pain relief.
FDA is encouraging pharmaceutical companies to develop abuse deterrent pain medicines to combat opioid addiction while ensuring chronic pain relief.
